Jane Street’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,212
| Closed | -$34.6K | – | 6120 |
|
|
2025
Q1 | $34.6K | Sell |
3,212
-8,760
| -73% | -$94.3K | ﹤0.01% | 5341 |
|
|
2024
Q4 | $153K | Sell |
11,972
-2,414
| -17% | -$30.9K | ﹤0.01% | 5205 |
|
|
2024
Q3 | $397K | Buy |
14,386
+5,596
| +64% | +$154K | ﹤0.01% | 4556 |
|
|
2024
Q2 | $255K | Sell |
8,790
-572
| -6% | -$16.6K | ﹤0.01% | 5173 |
|
|
2024
Q1 | $418K | Sell |
9,362
-5,841
| -38% | -$261K | ﹤0.01% | 4276 |
|
|
2023
Q4 | $590K | Buy |
15,203
+14,465
| +1,960% | +$561K | ﹤0.01% | 3927 |
|
|
2023
Q3 | $21.7K | Sell |
738
-2,366
| -76% | -$69.5K | ﹤0.01% | 4869 |
|
|
2023
Q2 | $197K | Sell |
3,104
-6,774
| -69% | -$431K | ﹤0.01% | 4591 |
|
|
2023
Q1 | $466K | Buy |
+9,878
| New | +$466K | ﹤0.01% | 3741 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5941 |
|
|
2022
Q3 | – | Sell |
-653
| Closed | -$85K | – | 6086 |
|
|
2022
Q2 | $85K | Sell |
653
-691
| -51% | -$89.9K | ﹤0.01% | 4798 |
|
|
2022
Q1 | $136K | Sell |
1,344
-3,103
| -70% | -$314K | ﹤0.01% | 4881 |
|
|
2021
Q4 | $688K | Buy |
4,447
+3,449
| +346% | +$534K | ﹤0.01% | 3134 |
|
|
2021
Q3 | $295K | Buy |
+998
| New | +$295K | ﹤0.01% | 3991 |
|